Dr Reddy’s Must Notify Celgene Of Plans To Sell Revlimid Generic In Australia
Three-Month Notice Period Will Give Originator The Opportunity To Seek An Injunction
Executive Summary
Australia’s Federal Court has ordered Dr Reddy’s to provide Celgene with three months written notice that it intends to bring a generic lenalidomide Revlimid rival to market.